PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference (RNAi ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company's investigational RNA interference (RNAi) therapeutic targeting Activin receptor-like kinase ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard operator, capable of changing its shape every few milliseconds so it can ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Tirzepatide works by imitating the effects of hormones called incretins. It mimics incretins known as GIP and GLP-1 by activating certain receptors (binding sites) in the body. This can help lower ...

The Summit’s three general poster sessions are held in Perry Atrium, Pettengill Hall.

Epigenetics refers to the reversible heritable mechanisms that function without altering the underlying DNA sequence, including DNA methylation or hydroxymethylation, RNA modification, histone ...

Aardvark claims the two mechanisms could be complementary and even boost the effects of popular “incretin” drugs like Wegovy. That hasn’t been proven in testing, though. Aardvark will evaluate the ...